$70.0M
The Series A round included backing from British Patient Capital, F-Prime Capital, and Sofinnova Partners.
TT
Tenpoint Therapeutics
Tenpoint Therapeutics develops engineered cell-based therapies to restore vision.
Cambridge, UK—Founded 2020
$70.0MTotal raised
Tenpoint Therapeutics is a biotechnology company developing cell-based therapeutics and in vivo reprogramming to reverse vision loss. The startup builds on scientific research in ocular therapies to replace lost and dysfunctional tissue in the eye.
Categories
Founders
PC
Pete Coffey
Scientific Founder
Ld
Lyndon da Cruz
Scientific Founder
DD
Deniz Dalkara
Scientific Founder
OG
Olivier Goureau
Scientific Founder
VK
Vanessa King
Scientific Founder
Vanessa brings extensive biotech leadership experience, including chief executive roles at King Bioventures, Virion Biotherapeutics, and Tenpoint Therapeutics. She also serves as a board member at AZAFAROS.
LinkedInTR
Thomas Reh
Scientific Founder
JS
José-Alain Sahel
Scientific Founder